242 related articles for article (PubMed ID: 21791690)
21. Polymorphisms of Genes Related to Function and Metabolism of Vitamin D in Esophageal Adenocarcinoma.
Singhal S; Kapoor H; Subramanian S; Agrawal DK; Mittal SK
J Gastrointest Cancer; 2019 Dec; 50(4):867-878. PubMed ID: 30187205
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of CD55 from Barrett's esophagus is associated with esophageal adenocarcinoma risk.
Murao T; Shiotani A; Fujita Y; Yamanaka Y; Kamada T; Manabe N; Hata J; Nishio K; Haruma K
J Gastroenterol Hepatol; 2016 Jan; 31(1):99-106. PubMed ID: 26202380
[TBL] [Abstract][Full Text] [Related]
23. The Barrett-associated variants at GDF7 and TBX5 also increase esophageal adenocarcinoma risk.
Becker J; May A; Gerges C; Anders M; Schmidt C; Veits L; Noder T; Mayershofer R; Kreuser N; Manner H; Venerito M; Hofer JH; Lyros O; Ahlbrand CJ; Arras M; Hofer S; Heinrichs SK; Weise K; Hess T; Böhmer AC; Kosiol N; Kiesslich R; Izbicki JR; Hölscher AH; Bollschweiler E; Malfertheiner P; Lang H; Moehler M; Lorenz D; Ott K; Schmidt T; Nöthen MM; Hackelsberger A; Schumacher B; Pech O; Vashist Y; Vieth M; Weismüller J; Knapp M; Neuhaus H; Rösch T; Ell C; Gockel I; Schumacher J
Cancer Med; 2016 May; 5(5):888-91. PubMed ID: 26783083
[TBL] [Abstract][Full Text] [Related]
24. Association of Biomarkers for Human Papillomavirus With Survival Among Adults With Barrett High-grade Dysplasia and Esophageal Adenocarcinoma.
Rajendra S; Sharma P; Gautam SD; Saxena M; Kapur A; Sharma P; Merrett N; Yang T; Santos LD; Pavey D; Sharaiha O; McKay O; Dixson H; Xuan W
JAMA Netw Open; 2020 Feb; 3(2):e1921189. PubMed ID: 32058552
[TBL] [Abstract][Full Text] [Related]
25. Gene expression alterations in formalin-fixed, paraffin-embedded Barrett esophagus and esophageal adenocarcinoma tissues.
Botelho NK; Schneiders FI; Lord SJ; Freeman AK; Tyagi S; Nancarrow DJ; Hayward NK; Whiteman DC; Lord RV
Cancer Biol Ther; 2010 Jul; 10(2):172-9. PubMed ID: 20543560
[TBL] [Abstract][Full Text] [Related]
26. Myo9B is associated with an increased risk of Barrett's esophagus and esophageal adenocarcinoma.
Menke V; Van Zoest KP; Moons LM; Pot RG; Siersema PD; Kuipers EJ; Kusters JG
Scand J Gastroenterol; 2012 Dec; 47(12):1422-8. PubMed ID: 22954106
[TBL] [Abstract][Full Text] [Related]
27. Identification of Prognostic Phenotypes of Esophageal Adenocarcinoma in 2 Independent Cohorts.
Sawas T; Killcoyne S; Iyer PG; Wang KK; Smyrk TC; Kisiel JB; Qin Y; Ahlquist DA; Rustgi AK; Costa RJ; Gerstung M; Fitzgerald RC; Katzka DA;
Gastroenterology; 2018 Dec; 155(6):1720-1728.e4. PubMed ID: 30165050
[TBL] [Abstract][Full Text] [Related]
28. Cyclin D1 polymorphism (G870A) and risk for esophageal adenocarcinoma.
Casson AG; Zheng Z; Evans SC; Geldenhuys L; van Zanten SV; Veugelers PJ; Porter GA; Guernsey DL
Cancer; 2005 Aug; 104(4):730-9. PubMed ID: 15971196
[TBL] [Abstract][Full Text] [Related]
29. LINE-1 expression and retrotransposition in Barrett's esophagus and esophageal carcinoma.
Doucet-O'Hare TT; Rodić N; Sharma R; Darbari I; Abril G; Choi JA; Young Ahn J; Cheng Y; Anders RA; Burns KH; Meltzer SJ; Kazazian HH
Proc Natl Acad Sci U S A; 2015 Sep; 112(35):E4894-900. PubMed ID: 26283398
[TBL] [Abstract][Full Text] [Related]
30. Global DNA methylation patterns in Barrett's esophagus, dysplastic Barrett's, and esophageal adenocarcinoma are associated with BMI, gender, and tobacco use.
Kaz AM; Wong CJ; Varadan V; Willis JE; Chak A; Grady WM
Clin Epigenetics; 2016; 8():111. PubMed ID: 27795744
[TBL] [Abstract][Full Text] [Related]
31. Predictive value of MicroRNAs in the progression of barrett esophagus to adenocarcinoma in a long-term follow-up study.
Revilla-Nuin B; Parrilla P; Lozano JJ; de Haro LF; Ortiz A; Martínez C; Munitiz V; de Angulo DR; Bermejo J; Molina J; Cayuela ML; Yélamos J
Ann Surg; 2013 May; 257(5):886-93. PubMed ID: 23059500
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic biomarkers in esophageal cancer.
Kaz AM; Grady WM
Cancer Lett; 2014 Jan; 342(2):193-9. PubMed ID: 22406828
[TBL] [Abstract][Full Text] [Related]
33. Prioritization and functional analysis of GWAS risk loci for Barrett's esophagus and esophageal adenocarcinoma.
Chen J; Ali MW; Yan L; Dighe SG; Dai JY; Vaughan TL; Casey G; Buas MF
Hum Mol Genet; 2022 Feb; 31(3):410-422. PubMed ID: 34505128
[TBL] [Abstract][Full Text] [Related]
34. Identification of a key role of widespread epigenetic drift in Barrett's esophagus and esophageal adenocarcinoma.
Luebeck EG; Curtius K; Hazelton WD; Maden S; Yu M; Thota PN; Patil DT; Chak A; Willis JE; Grady WM
Clin Epigenetics; 2017; 9():113. PubMed ID: 29046735
[TBL] [Abstract][Full Text] [Related]
35. Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma.
Samuels TL; Altman KW; Gould JC; Kindel T; Bosler M; MacKinnon A; Hagen CE; Johnston N
Laryngoscope; 2019 Dec; 129(12):2687-2695. PubMed ID: 31046139
[TBL] [Abstract][Full Text] [Related]
36. The Y-chromosome F haplogroup contributes to the development of Barrett's esophagus-associated esophageal adenocarcinoma in a white male population.
Westra WM; Rygiel AM; Mostafavi N; de Wit GMJ; Roes AL; Moons LMG; Peppelenbosch MP; Ouburg S; Morré SA; Jacobs M; Siersema PD; Repping S; Wang KK; Krishnadath KK
Dis Esophagus; 2020 Sep; 33(9):. PubMed ID: 32129453
[TBL] [Abstract][Full Text] [Related]
37. Comparison of cancer-associated genetic abnormalities in columnar-lined esophagus tissues with and without goblet cells.
Bandla S; Peters JH; Ruff D; Chen SM; Li CY; Song K; Thoms K; Litle VR; Watson T; Chapurin N; Lada M; Pennathur A; Luketich JD; Peterson D; Dulak A; Lin L; Bass A; Beer DG; Godfrey TE; Zhou Z
Ann Surg; 2014 Jul; 260(1):72-80. PubMed ID: 24509200
[TBL] [Abstract][Full Text] [Related]
38. Systems Biology Analyses Show Hyperactivation of Transforming Growth Factor-β and JNK Signaling Pathways in Esophageal Cancer.
Blum AE; Venkitachalam S; Ravillah D; Chelluboyina AK; Kieber-Emmons AM; Ravi L; Kresak A; Chandar AK; Markowitz SD; Canto MI; Wang JS; Shaheen NJ; Guo Y; Shyr Y; Willis JE; Chak A; Varadan V; Guda K
Gastroenterology; 2019 May; 156(6):1761-1774. PubMed ID: 30768984
[TBL] [Abstract][Full Text] [Related]
39. eQTL Set-Based Association Analysis Identifies Novel Susceptibility Loci for Barrett Esophagus and Esophageal Adenocarcinoma.
Wang X; Gharahkhani P; Levine DM; Fitzgerald RC; Gockel I; Corley DA; Risch HA; Bernstein L; Chow WH; Onstad L; Shaheen NJ; Lagergren J; Hardie LJ; Wu AH; Pharoah PDP; Liu G; Anderson LA; Iyer PG; Gammon MD; Caldas C; Ye W; Barr H; Moayyedi P; Harrison R; Watson RGP; Attwood S; Chegwidden L; Love SB; MacDonald D; deCaestecker J; Prenen H; Ott K; Moebus S; Venerito M; Lang H; Mayershofer R; Knapp M; Veits L; Gerges C; Weismüller J; Reeh M; Nöthen MM; Izbicki JR; Manner H; Neuhaus H; Rösch T; Böhmer AC; Hölscher AH; Anders M; Pech O; Schumacher B; Schmidt C; Schmidt T; Noder T; Lorenz D; Vieth M; May A; Hess T; Kreuser N; Becker J; Ell C; Tomlinson I; Palles C; Jankowski JA; Whiteman DC; MacGregor S; Schumacher J; Vaughan TL; Buas MF; Dai JY
Cancer Epidemiol Biomarkers Prev; 2022 Sep; 31(9):1735-1745. PubMed ID: 35709760
[TBL] [Abstract][Full Text] [Related]
40. Isoforms of RNF128 Regulate the Stability of Mutant P53 in Barrett's Esophageal Cells.
Ray D; Ray P; Ferrer-Torres D; Wang Z; Nancarrow D; Yoon HW; San Martinho M; Hinton T; Owens S; Thomas D; Jiang H; Lawrence TS; Lin J; Lagisetty K; Chang AC; Beer DG
Gastroenterology; 2020 Feb; 158(3):583-597.e1. PubMed ID: 31715145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
